Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation

<div>Design of the newly proposed VEGFR-2 inhibitors. A: hydrogen bond acceptor; D: hydrogen bond donor; HRB: hinge-region binding; HT: hydrophobic tail.</div>

Oxidative Medicine and Cellular Longevity

fig2

Figure 2

Figure 2: Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation 

Figure 2 | Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation 